CU23040A3 - Sistema de administracion controlada de droga por via oral que proporciona control temporal y espacial - Google Patents

Sistema de administracion controlada de droga por via oral que proporciona control temporal y espacial

Info

Publication number
CU23040A3
CU23040A3 CU20010067A CU20010067A CU23040A3 CU 23040 A3 CU23040 A3 CU 23040A3 CU 20010067 A CU20010067 A CU 20010067A CU 20010067 A CU20010067 A CU 20010067A CU 23040 A3 CU23040 A3 CU 23040A3
Authority
CU
Cuba
Prior art keywords
route
administration system
space control
provides temporary
controlled administration
Prior art date
Application number
CU20010067A
Other languages
English (en)
Inventor
Naresh Talwar
Himadri Sen
John H Staniforth
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/152,932 external-priority patent/US6261601B1/en
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of CU23040A3 publication Critical patent/CU23040A3/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CU20010067A 1998-09-14 1999-01-19 Sistema de administracion controlada de droga por via oral que proporciona control temporal y espacial CU23040A3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/152,932 US6261601B1 (en) 1997-09-19 1998-09-14 Orally administered controlled drug delivery system providing temporal and spatial control
PCT/IB1999/000078 WO2000015198A1 (en) 1998-09-14 1999-01-19 Orally administered controlled drug delivery system providing temporal and spatial control

Publications (1)

Publication Number Publication Date
CU23040A3 true CU23040A3 (es) 2005-04-14

Family

ID=22545063

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20010067A CU23040A3 (es) 1998-09-14 1999-01-19 Sistema de administracion controlada de droga por via oral que proporciona control temporal y espacial

Country Status (40)

Country Link
EP (2) EP1281397A1 (es)
JP (1) JP2002524494A (es)
CN (1) CN1186013C (es)
AP (1) AP1659A (es)
AR (1) AR022672A1 (es)
AT (1) ATE245414T1 (es)
AU (1) AU758324B2 (es)
BG (1) BG105339A (es)
BR (1) BR9913696A (es)
CA (1) CA2343760A1 (es)
CO (1) CO5130022A1 (es)
CU (1) CU23040A3 (es)
CZ (1) CZ2001901A3 (es)
DE (1) DE69909801T2 (es)
DK (1) DK1107741T3 (es)
EA (2) EA004443B1 (es)
EE (1) EE200100153A (es)
ES (1) ES2204098T3 (es)
GE (1) GEP20043216B (es)
HR (1) HRP20010187B1 (es)
HU (1) HUP0103632A3 (es)
ID (1) ID29843A (es)
IL (1) IL141977A0 (es)
IS (1) IS5885A (es)
MX (1) MXPA01002634A (es)
MY (1) MY127952A (es)
NO (1) NO20011276L (es)
NZ (2) NZ523747A (es)
OA (1) OA11652A (es)
PE (1) PE20001058A1 (es)
PL (1) PL346798A1 (es)
PT (1) PT1107741E (es)
SI (1) SI1107741T1 (es)
SK (1) SK285478B6 (es)
SV (1) SV1999000152A (es)
TR (1) TR200100731T2 (es)
UA (1) UA73287C2 (es)
UY (1) UY25710A1 (es)
WO (1) WO2000015198A1 (es)
ZA (1) ZA995839B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1485A (en) * 2000-03-03 2005-10-31 Ranbaxy Laboratories Ltd Orally administered controlled delivery system for once daily administration of ciprofloxacin.
AU2006202275A1 (en) * 2000-06-26 2006-06-22 Bayer Healthcare Ag Sustained-release preparations of quinolone antibiotics and method for preparation thereof
DE10031043A1 (de) 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
WO2002011726A1 (en) * 2000-08-08 2002-02-14 Daiichi Pharmaceutical Co., Ltd. Highly absorbable solid preparation
IN192748B (es) * 2000-08-29 2004-05-15 Ranbaxy Lab Ltd
WO2002045695A2 (en) 2000-12-05 2002-06-13 Alexander Macgregor Hydrostatic delivery system for controlled delivery of agent
PL370793A1 (en) * 2001-07-04 2005-05-30 Sun Pharmaceutical Industries Limited Gastric retention controlled drug delivery system
MXPA04001388A (es) * 2001-08-16 2004-05-27 Oregon State Dispositivo de retencion gastrica expandible.
US6673369B2 (en) * 2001-08-29 2004-01-06 Ranbaxy Laboratories Limited Controlled release formulation
AU2002351798A1 (en) * 2001-10-29 2003-05-12 Labopharm Inc. Methods and dosage forms for improving the bioavailability of therapeutic agents
WO2003041656A2 (en) * 2001-11-13 2003-05-22 Yamanouchi Pharma Technologies, Inc. Soluble drug extended release system
DE60117712T2 (de) 2001-11-19 2006-11-16 Lupin Ltd., Mumbai Pharmazeutische zusammensetzung für die kontrollierte freisetzung eines beta-lactam-antibiotikums
EP1501521B1 (en) * 2002-04-23 2007-05-02 Lupin Limited Long acting compositions comprising zidovudine and/or lamivudine
WO2005018613A1 (de) * 2003-08-26 2005-03-03 Mandapro Ag Pellets für die orale applikation von pharmazeutischen wirkstoffen
DE602005025767D1 (de) * 2004-06-28 2011-02-17 Abbott Healthcare Products Bv Orale tedisamilformulierungen mit magenretentionseigenschaften und verzögerter freisetzung
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
GB0501810D0 (en) * 2005-01-28 2005-03-09 Pharmakodex Ltd Chemotherapeutic formulations
CA2613407A1 (en) * 2005-06-29 2007-01-04 Panacea Biotec Ltd. Pharmaceutical sustained release compositions and processes thereof
DE602005007205D1 (de) * 2005-07-19 2008-07-10 Ethypharm Sa Gastroretentive Zusammensetzungen und Verfahren zur Herstellung
GB0515492D0 (en) * 2005-07-28 2005-08-31 Reckitt Benckiser Healthcare Improvements in or relating to compositions,articles and methods
KR20080076382A (ko) * 2007-02-15 2008-08-20 (주)아모레퍼시픽 실로스타졸의 제어방출 제제 및 그 제조방법
ZA200903854B (en) * 2008-06-19 2011-02-23 Univ Of The Witwatesrand Johannesburg A gastroretentive pharmaceutical dosage form
JP2012500230A (ja) 2008-08-18 2012-01-05 北京天衡▲薬▼物研究院 胃内滞留薬物放出システム及びその製造方法と使用
WO2011125075A2 (en) 2010-04-08 2011-10-13 Fdc Limited A novel gastroretentive delivery of macrolide
EP2415460A1 (de) * 2010-08-03 2012-02-08 ratiopharm GmbH Orale Darreichungsform von Pregabalin
TWI732337B (zh) * 2014-06-20 2021-07-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
EP3220894B1 (en) 2014-11-19 2021-03-10 DuPont Nutrition USA, Inc. Nanosuspension formulation
US10588863B2 (en) 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
US10987311B2 (en) 2017-06-16 2021-04-27 Kashiv Specialty Pharmaceuticals, Llc Extended release compositions comprising pyridostigmine
WO2018232413A1 (en) 2017-06-16 2018-12-20 Kashiv Pharma Llc Gastroretentive dosage forms for sustained drug delivery
ES2861153T3 (es) 2018-06-18 2021-10-05 Composiciones de liberación prolongada que comprenden piridostigmina
DK3628004T3 (da) 2018-06-27 2021-12-20 Amneal Complex Products Res Llc Selvregulerende osmotiske mave-tarm tilbageholdende leveringssystemer til lægemiddel
CN110448535A (zh) * 2019-09-04 2019-11-15 湖南宇山玉月农业科技有限公司 一种裂褶菌素胃漂浮片
CN111116794A (zh) * 2019-12-20 2020-05-08 蚌埠市鑫晟新材料科技有限公司 一种中性造纸用聚合材料的制备方法
CN115715765A (zh) * 2021-08-24 2023-02-28 江苏万邦生化医药集团有限责任公司 一种悬浮片剂
CN113768898A (zh) * 2021-09-14 2021-12-10 江苏万邦生化医药集团有限责任公司 悬浮的胶囊片

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0798742B2 (ja) * 1986-07-03 1995-10-25 ゼリア新薬工業株式会社 徐放性製剤組成物
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
JPH0624959A (ja) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk 胃内浮遊型薬物徐放性固形製剤

Also Published As

Publication number Publication date
ID29843A (id) 2001-10-18
HRP20010187B1 (en) 2004-04-30
OA11652A (en) 2004-12-08
SK285478B6 (sk) 2007-02-01
HRP20010187A2 (en) 2002-04-30
HUP0103632A3 (en) 2005-06-28
PL346798A1 (en) 2002-02-25
HUP0103632A2 (hu) 2002-02-28
UA73287C2 (en) 2005-07-15
CA2343760A1 (en) 2000-03-23
DE69909801T2 (de) 2004-06-03
AP2001002098A0 (en) 2001-03-31
EE200100153A (et) 2002-06-17
ATE245414T1 (de) 2003-08-15
SV1999000152A (es) 2000-07-03
EA200300847A1 (ru) 2003-12-25
MY127952A (en) 2007-01-31
NO20011276L (no) 2001-05-10
EA200100346A1 (ru) 2001-10-22
CO5130022A1 (es) 2002-02-27
NZ510487A (en) 2003-04-29
DK1107741T3 (da) 2003-11-17
AU1779499A (en) 2000-04-03
EP1107741B1 (en) 2003-07-23
IL141977A0 (en) 2002-03-10
BG105339A (en) 2001-11-30
EP1107741A1 (en) 2001-06-20
GEP20043216B (en) 2004-04-26
NZ523747A (en) 2004-04-30
SK3472001A3 (en) 2001-10-08
WO2000015198A1 (en) 2000-03-23
JP2002524494A (ja) 2002-08-06
PE20001058A1 (es) 2000-10-05
AR022672A1 (es) 2002-09-04
AP1659A (en) 2006-09-06
NO20011276D0 (no) 2001-03-13
CN1186013C (zh) 2005-01-26
CZ2001901A3 (cs) 2001-08-15
BR9913696A (pt) 2001-10-09
HK1037967A1 (en) 2002-03-01
CN1325299A (zh) 2001-12-05
PT1107741E (pt) 2003-12-31
UY25710A1 (es) 2000-03-31
DE69909801D1 (de) 2003-08-28
TR200100731T2 (tr) 2001-06-21
ES2204098T3 (es) 2004-04-16
SI1107741T1 (en) 2004-02-29
AU758324B2 (en) 2003-03-20
ZA995839B (en) 2000-03-28
IS5885A (is) 2001-03-12
EA004443B1 (ru) 2004-04-29
EA005767B1 (ru) 2005-06-30
MXPA01002634A (es) 2002-06-04
EP1281397A1 (en) 2003-02-05

Similar Documents

Publication Publication Date Title
CU23040A3 (es) Sistema de administracion controlada de droga por via oral que proporciona control temporal y espacial
PT1051217E (pt) Sistema de controlo osmotico de administracao de medicamento
BR9609796A (pt) Sistema transcórneo de liberação de droga
PT877599E (pt) Administracao continua de leuprolido utilizando um sistema implantavel
DE69935681D1 (de) Vorrichtungen zur Medikamentverabreichung
PT876815E (pt) Sistema de distribuicao de drogas para duas ou mais substancias activas
EE200000546A (et) Aerosoolistatud toimeaine manustamissüsteem
BR9900981B1 (pt) Sistema de transcodificação
EE200100714A (et) Farmatseutiliste ravimvormide pihustamissüsteemidja -meetodid
DE69842026D1 (de) Dynamisches instandhaltung verwaltungssystem
BR9406050A (pt) Sistema fechado de liberação de medicamento
BR9407725A (pt) Sistema de liberaçao de substância ativa
PT1066212E (pt) Sistema elevador
IT1298764B1 (it) Sistema di controllo dentale
IT1293038B1 (it) Sistema divisorio per edifici
ITMI970806U1 (it) Sistema deodorante per gabinetti igienici
IT230805Y1 (it) Sistema di costruzione monouso per allestimenti provvisori
IT1292960B1 (it) Sistema modulare intraorale
IT1304899B1 (it) Metodo e dispositivo per la somministrazione di farmaci
BR9503947A (pt) Sistema de trilhos
BR9400514A (pt) Sistema modúlar de informatização de trÂnsito
BR7102337U (pt) Sistema de convenio farmaceutico
BR9705596A (pt) Sistema de veiculação
BR9400250A (pt) Sistema modular de construçao civil
BR9404049A (pt) Sistema de construção modular